VPS53 (Vacuolar Protein Sorting 53) is a critical core component of two related vesicle tethering complexes—HOPS (Homotypic fusion and Vacuolar Protein Sorting) and CORVET (Class C Core Vacuolar/Endosomal Tethering). These complexes are essential for mediating membrane fusion events in the endosomal-lysosomal pathway, which is fundamental to cellular homeostasis, protein degradation, and autophagy. VPS53 plays a central role in tethering late endosomes and autophagosomes to lysosomes, enabling the proper degradation of protein aggregates, damaged organelles, and cellular debris—processes that are particularly important in neurons given their long lifespan and non-dividing nature.
The discovery that VPS53 mutations cause autosomal recessive hereditary spastic paraplegia (HSP) with neurodevelopmental regression (Bomont et al., 2020) has highlighted the critical importance of this protein in human neurological function. Furthermore, dysfunction of the HOPS complex, which includes VPS53 as a core subunit, has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease (Miller et al., 2019). This makes VPS53 an important protein for understanding neurodegenerative disease mechanisms and potentially for therapeutic targeting.
The study of VPS53 and the HOPS/CORVET complexes has evolved from basic yeast genetics to a detailed understanding of their critical roles in mammalian neurobiology:
Yeast origins: VPS53 was first identified in Saccharomyces cerevisiae as part of the vacuolar protein sorting pathway, with mutants showing defects in vacuolar hydrolase delivery.
Complex discovery: The HOPS complex was first characterized in yeast as a critical mediator of vacuolar fusion, with VPS53 representing one of its core subunits.
Mammalian studies: Subsequent work in mammals revealed that the HOPS complex is essential for lysosomal trafficking and autophagosome-lysosome fusion.
Disease connections: The identification of VPS53 mutations causing hereditary spastic paraplegia in humans established a direct link between VPS53 dysfunction and neurodegenerative disease (Feinstein et al., 2019).
Therapeutic implications: Recent research has focused on understanding how VPS53 dysfunction contributes to common neurodegenerative diseases and potential therapeutic approaches.
| VPS53 Protein | |
|---|---|
| Protein Name | Vacuolar Protein Sorting 53 |
| Gene | [VPS53](/genes/vps53) |
| UniProt ID | [Q9H5R0](https://www.uniprot.org/uniprot/Q9H5R0) |
| PDB ID | 6Q19, 6Q1A |
| Molecular Weight | 79 kDa (672 aa) |
| Subcellular Localization | Endosomes, Lysosomes, Golgi apparatus |
| Protein Family | HOPS complex, CORVET complex |
| Tissue Distribution | Brain (neurons, glia), ubiquitous |
VPS53 is a 672-amino acid protein with a molecular weight of approximately 79 kDa. The protein contains several structural domains that enable its function in the HOPS and CORVET complexes:
N-terminal domain (aa 1-200): Interactions with other HOPS/CORVET subunits, particularly VPS16 and VPS33. This region contains binding sites for the core complex assembly.
Central region (aa 200-450): Scaffold for complex formation, providing the structural framework for the hexameric HOPS complex. This region contains alpha-helical domains that mediate subunit-subunit interactions.
C-terminal region (aa 450-672): Conserved WD40-like beta-propeller repeats that may function in protein-protein interactions and membrane recognition. This domain is important for cargo recognition and recruitment.
Crystal structures of the VPS53-containing HOPS complex have revealed (Ostrowicz et al., 2015):
VPS53 functions as a critical component of the HOPS and CORVET tethering complexes, which mediate membrane fusion in the endosomal-lysosomal pathway:
The HOPS complex (comprising VPS11, VPS16, VPS18, VPS33A/B, VPS39, and VPS53) is the central coordinator of lysosomal fusion events (Spang, 2016):
The CORVET complex (VPS11, VPS16, VPS18, VPS33A/B, VPS39, and VPS53) shares core subunits with HOPS but has distinct functions:
Beyond being a core complex member, VPS53 has specific functions:
VPS53 is particularly important in neurons (Harris et al., 2020):
VPS53 exhibits a broad expression pattern with particularly high levels in the nervous system:
High expression in:
Cellular localization:
Brain regions with high expression:
VPS53 interacts with multiple proteins within the HOPS/CORVET complexes and with regulatory proteins:
| Protein | Interaction Type | Function |
|---|---|---|
| VPS11 | Direct binding | Core HOPS/CORVET subunit |
| VPS16 | Direct binding | Core complex member |
| VPS18 | Direct binding | Core complex member |
| VPS33A/B | Direct binding | SM protein regulator |
| VPS39 | Direct binding | HOPS-specific subunit |
| VPS52 | Complex formation | CORVET-specific subunit |
| Rab7 | GTPase interaction | Late endosomal regulation |
| SNARE proteins | Regulation | Membrane fusion machinery |
| LAMP1/2 | Co-localization | Lysosomal membrane protein |
| mTOR | Signaling | Nutrient sensing regulation |
VPS53 is critical for autophagosome-lysosome fusion (Zhang et al., 2021):
VPS53 mediates multiple endosomal trafficking steps (Nomura et al., 2016):
VPS53 maintains lysosomal homeostasis (Ballabio & Bonifacino, 2021):
VPS53 mutations cause autosomal recessive hereditary spastic paraplegia with neurodevelopmental regression (Marti et al., 2021):
VPS53 and the HOPS complex contribute to AD pathogenesis (Nixon et al., 2017):
VPS53 is implicated in PD through its role in lysosomal trafficking (Abeliovich & Slack, 2019):
VPS53 contributes to ALS through lysosomal dysfunction mechanisms (Chen et al., 2020):
VPS53 may contribute to Huntington's disease pathogenesis:
VPS53 mutations cause this severe neurodevelopmental disorder (Feinstein et al., 2019):
Targeting VPS53 pathways represents a potential therapeutic strategy:
Studying VPS53 in disease:
VPS53 as a biomarker:
VPS53 sequencing is available for:
VPS53 represents a critical nexus in the endosomal-lysosomal pathway, serving as an essential component of the HOPS and CORVET tethering complexes that mediate membrane fusion events fundamental to cellular homeostasis. The protein's central role in autophagy, lysosomal trafficking, and synaptic function makes it particularly important for neuronal health, given the unique degradative challenges faced by long-lived neurons. The identification of VPS53 mutations causing hereditary spastic paraplegia has established a direct link between VPS53 dysfunction and human neurological disease, while research into common neurodegenerative diseases has revealed contributions to Alzheimer's disease, Parkinson's disease, ALS, and Huntington's disease through impaired autophagic-lysosomal clearance. Understanding VPS53 function and developing therapeutic strategies to enhance its activity represents an important frontier in neurodegenerative disease research.